Metabolic care, reviewed by licensed clinicians.
OPTMZE connects eligible patients with independent U.S.-licensed clinicians. Completing intake does not guarantee a prescription. If treatment is appropriate, Semaglutide is $239/mo and Tirzepatide is $345/mo, fulfilled through a licensed pharmacy partner.
Licensed review
Clinical intake is reviewed by the provider network.
Care is not automated. After you complete intake, an affiliated licensed provider through Scriptful Inc. reviews your information and decides whether treatment is clinically appropriate.
Two treatments
Semaglutide $239/mo · Tirzepatide $345/mo if prescribed.
Those prices apply only if a licensed provider prescribes. The public catalog is limited to these two options. Compounded medication is used only when clinically appropriate and is not FDA-approved.
Private fulfillment
Discreet shipping when a prescription is issued.
If prescribed, medication is dispensed by a licensed U.S. pharmacy partner and shipped in discreet packaging. Availability depends on your location, clinical review, and pharmacy authorization.
Independent Clinical Review
Intake reviewed by affiliated U.S.-licensed clinicians when you submit.
Personalized Treatment Plans
Plans considered only when clinically appropriate for you.
Convenient Telehealth
Access care from the comfort and privacy of your own home.
Discreet Shipping When Prescribed
Private packaging when a prescription is fulfilled by a licensed pharmacy partner.
Ongoing Medical Support
Follow-up through your care team when treatment continues.
Transparent Pricing
Clear monthly pricing from $239/mo if prescribed.